Industry update Alcanna, YSS to target cannabis value segment with retail merger New company to be named Nova Cannabis, with most of its 53 stores in three provinces re-branded as Value Buds Jared GnamJanuary 18, 2021
Industry update Aphria stock hits 2-year high on record Q2 sales The firm's valuation is rocketing along with most pot stocks, but uncertainty remains if it can better capitalize on both domestic and international markets Nick LabaJanuary 14, 2021
Industry update Hexo, Molson Coors launch first US CBD drinks in Colorado Beer giant and Quebec pot producer plan to expand CBD beverage line as American regulatory framework develops Jared GnamJanuary 13, 2021
Industry update Virginia set to be first Southern state to legalize adult-use cannabis Gov. Ralph Northam is confident the new law will pass this year, paving the road for racial equity and tax revenue Jared GnamJanuary 13, 2021
Industry update Ontario Cannabis Store details ‘core assortment’ and craft programs The OCS has around 200 products slated for removal by March and plans to designate craft product by the spring Nick LabaJanuary 12, 2021
Industry update Organigram shares sink as sales shrink High-cost cultivation without premium brands is a losing combo for the New Brunswick producer, analyst says Jared GnamJanuary 12, 2021
Industry update US FDA unveils plan to gather ‘real-world’ data to fill CBD research gaps After two years of delaying regulations, the agency looks to improve data-gathering methods on CBD product safety Jared GnamJanuary 11, 2021
Industry update Inner Spirit leads cutthroat Canadian cannabis retail sector with 70 stores In tight competition with High Tide and Fire & Flower, the firm edges ahead in the retail footprint race with its expanding franchise model Nick LabaJanuary 7, 2021
Industry update WeedMD CEO exits after less than a year Angelo Tsebelis is replaced by chairman George Scorsis as the Ontario producer's interim CEO Jared GnamJanuary 4, 2021
Industry update MagicMed attracts investors to advance library of psychedelic derivatives After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments Jared GnamDecember 23, 2020